Article Details
Retrieved on: 2021-03-17 14:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... and 52% stock transaction valued at approximately $12bn. Financing reached $11.4bn in biopharma, $1.2bn in device, and $1.5bn in diagnostics.
Article found on: invivo.pharmaintelligence.informa.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here